← k3vl4r
Log inGet started →

DNA (Ginkgo Bioworks) Price Forecast

AI-generated price forecast for Ginkgo Bioworks (DNA) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads DNA as split 1/1 across its horizons (1 of 2 timeframes pointing up), with a last price of 12.38. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

12.38

AI outlook

split 1/1

Timeframes up

1 / 2

Share𝕏PostTelegram

DNA forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-18.03%0%
Weekly~1.8 years out▲ Up+609.57%—

Latest DNA news

From the market-news feed the forecasts are read against.

  • Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know · Yahoo · Sep 23
  • Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? · Yahoo · Sep 18
  • Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts · Yahoo · Sep 16
  • Entrega to Receive $5M Investment from Lilly To Advance Proprietary Oral Delivery Technology for Peptides · Benzinga · Sep 16
  • Ginkgo Bioworks Holdings Consensus Price Target Cut by 22.22% to $7.14 · Fintel · Sep 16

🔒

See the full DNA forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

DNA forecast — frequently asked

Will DNA go up?

K3vl4r's AI model currently reads DNA as split 1/1 — 1 of 2 forecast horizons point up, so the overall read is mixed. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the DNA price prediction for 2026?

K3vl4r's model projects DNA toward $12.53 over the next ~3 months, a -0.2% move from $12.55. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could DNA reach?

Over its longest horizon (~~1.8 years), the model's projected target for DNA is $13.61 (+6.1% vs $12.83). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

BEAMVRTXAGIONBIXSUPNMRNANTLAIOVAPRTAIRWDUTHRBNTXTMDXGERN

Will DNA reach…?

Will DNA reach $20.00?Will DNA reach $25.00?Will DNA reach $50.00?

Or see the full DNA price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare DNA

DNA vs BEAMDNA vs VRTXDNA vs AGIODNA vs NBIXDNA vs SUPNDNA vs MRNA

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.